SUVEN LIFE SCIENCES LTD
SUVEN.NS
₹ 147.41
1%

Suven Life Sciences Ltd

Suven Life Sciences Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Suven Life Sciences is ₹ 147.41 that is ₹ 1.11 -0.75% with respect to the previous day’s close price. The stock price of Suven Life Sciences was last updated 12 hours ago.

Suven Life Sciences Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Suven Life Sciences Live Share Price Analysis

SUVEN LIFE SCIENCES LTD
₹ 147.41
Open ₹ 148.80
High ₹ 151.24
Marketcap 34.27B
Close ₹ 147.41
Low ₹ 143.60
Volume ₹ 620,627.00

The stock of Suven Life Sciences Ltd strated the trade at an Open price of ₹ 148.80 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 151.24 and an Intraday Low price of ₹ 143.60%. As per last updated 12 hours ago, the Shares of Suven Life Sciences were trading at a price of ₹ 147.41 which is ₹ 1.11 -0.75% as compared the price ₹ 148.52 at which the stock close on the previous trading day. The total traded volume for the day stood at 620,627 number of shares.

Candlestick Chart of Suven Life Sciences Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Suven Life Sciences Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 147.41₹ 74.50₹ 169.30

Here is Suven Life Sciences’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 169.30. On the lower side, the stock has been to the 52 weeks low price level of ₹ 74.50. It’s last traded price was ₹ 147.41 as on last update 12 hours ago. The one-year line chart clearly shows how the price of Suven Life Sciences’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ -6.68 per share (EPS TTM) in the trailing twelve months period. Suven Life Sciences’s last annual dividend rate was %, which translates to a % of annual dividend yield.

Line Chart of Suven Life Sciences Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Suven Life Sciences

Suven Life Sciences Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Suven Life Sciences are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Suven Life Sciences

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
AARTIDRUGS.NSAARTI DRUGS LTD.
₹ 445.15
NSE
₹ 1.15
0.26%
AAYUSH.BOAAYUSH WELLNESS LIMITED
₹ 184.15
BSE
₹ 3.60
1.99%
ABBOTINDIA.NSABBOTT INDIA LIMITED
₹ 28,648.75
NSE
₹ 99.55
0.35%
ADESHWAR.BOAdeshwar Meditex Limited
₹ 23.00
BSE
₹ 0.0000
0.00%
ADVENZYMES.NSADVANCED ENZYME TECH LTD
₹ 377.40
NSE
₹ 3.20
0.84%
ADVIKLA.BOADVIK LABORATORIES LTD.
₹ 4.13
BSE
₹ 0.0000
0.00%
AJANTPHARM.NSAJANTA PHARMA LIMITED
₹ 2,807.45
NSE
₹ 31.50
1.11%
ALBERTDAVD.NSALBERT DAVID LIMITED
₹ 1,410.80
NSE
₹ 30.00
2.08%
ALCHEM.NSALCHEM.NS,0P0000B9XC,0
₹ 3.15
NSE
₹ 0.0000
0.00%
ALEMBICLTD.NSALEMBIC LIMITED
₹ 147.47
NSE
₹ 0.51
0.34%

About Suven Life Sciences

Suven Life Sciences Ltd is a Private Company. The company operates in the Pharmaceuticals & Drugs sector. It is a bio-pharmaceutical company. Incorporated in 1989, it has around 32 years of operations. Suven Life Sciences live share price is ₹ 147.41. It is a Small Cap stock and had a market capitalization of ₹ 34,273,859,584.00 as on 12 hours ago.

  • Suven Life Sciences is engaged in the business of manufacture and sale of bulk drugs and intermediaries.
  • The Company’s segments include Manufacturing (CRAMS), which develops and produces bulk drugs and intermediates under contract manufacturing services; Services (DDDSS), which consists of collaborative research projects (CRP), clinical trials, and testing and analysis services, and Research and Development.
  • Its products consist of active pharmaceutical ingredients (APIs), including Aripiprazole, Armodafinil, Calcium Acetate, Carprofen, Deferasirox, Doxofylline, Entacapone, Fenoprofen Calcium, Rosuvastatin Calcium, Sitagliptin Phosphate and Solifenacin succinate, and intermediates, including 2-nitro phenyl acetic acid and 3,4-dichlorobenzylamine.
  • The Company is engaged in the drug discovery specializing in central nervous system (CNS)-based programs with over four of the molecules in pipeline under clinical phase of development.

The registered office of Suven Life Sciences is located in Hyderabad, Telangana. The registrar and share transfer agent for Suven Life Sciences is K FIN Technologies Pvt Ltd. The Stock Exchanges on which shares of Suven Life Sciences Ltd is listed includes BSE, NSE, MCX.

SUVEN LIFE SCIENCES LTD
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 141
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and Ropanicant (SUVN-911), Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is developing Usmarapride (SUVN-D4010), a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
Address8-2-334, SDE Serene Chambers, Hyderabad, India
CountryIndia
Phone91 40 2354 1142
Websitehttps://www.suven.com

Suven Life Sciences Recent News

No Recent News found for Suven Life Sciences Ltd.